10.41
0.15 (1.46%)
| Previous Close | 10.26 |
| Open | 10.25 |
| Volume | 250,719 |
| Avg. Volume (3M) | 1,196,945 |
| Market Cap | 1,400,717,568 |
| Price / Earnings (Forward) | 10.47 |
| Price / Sales | 0.410 |
| Price / Book | 0.890 |
| 52 Weeks Range | |
| Earnings Date | 25 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -6.57% |
| Operating Margin (TTM) | 8.92% |
| Diluted EPS (TTM) | -1.67 |
| Quarterly Revenue Growth (YOY) | 0.20% |
| Quarterly Earnings Growth (YOY) | 39.00% |
| Total Debt/Equity (MRQ) | 142.94% |
| Current Ratio (MRQ) | 1.24 |
| Operating Cash Flow (TTM) | 546.69 M |
| Levered Free Cash Flow (TTM) | 240.27 M |
| Return on Assets (TTM) | 4.11% |
| Return on Equity (TTM) | -12.88% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | AdaptHealth Corp. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 4.0 |
| Average | 1.00 |
|
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 11.90% |
| % Held by Institutions | 94.94% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Oep Capital Advisors, L.P. | 30 Sep 2024 | 13,818,180 |
| Skyknight Capital, L.P. | 30 Sep 2024 | 8,580,443 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 14.00 (Baird, 34.49%) | Buy |
| Median | 12.00 (15.27%) | |
| Low | 11.00 (RBC Capital, 5.67%) | Buy |
| Average | 12.40 (19.12%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 9.98 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 19 Nov 2024 | 11.00 (5.67%) | Buy | 9.74 |
| Truist Securities | 15 Nov 2024 | 12.00 (15.27%) | Buy | 9.64 |
| Baird | 06 Nov 2024 | 14.00 (34.49%) | Buy | 10.18 |
| Canaccord Genuity | 06 Nov 2024 | 13.00 (24.88%) | Buy | 10.18 |
| UBS | 06 Nov 2024 | 12.00 (15.27%) | Buy | 10.18 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 03 Dec 2024 | Announcement | AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer |
| 26 Nov 2024 | Announcement | AdaptHealth Corp. to Participate in the BofA Securities Home Care Conference 2024 |
| 12 Nov 2024 | Announcement | AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference |
| 05 Nov 2024 | Announcement | AdaptHealth Corp. Announces Third Quarter 2024 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |